Equities

Curaleaf Holdings Inc

CURA:TOR

Curaleaf Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)3.10
  • Today's Change-0.05 / -1.59%
  • Shares traded689.62k
  • 1 Year change-30.49%
  • Beta1.3900
Data delayed at least 15 minutes, as of Nov 14 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments92163299
Total Receivables, Net634563
Total Inventory216235248
Prepaid expenses302936
Other current assets, total1818081
Total current assets419652727
Property, plant & equipment, net833871705
Goodwill, net627625606
Intangibles, net1,1721,2131,036
Long term investments2.482.804.40
Note receivable - long term30330.84
Other long term assets131524
Total assets3,0973,4153,105
LIABILITIES
Accounts payable798127
Accrued expenses117120100
Notes payable/short-term debt000
Current portion long-term debt/capital leases556511
Other current liabilities, total243231179
Total current liabilities494497316
Total long term debt917952721
Total debt9721,017732
Deferred income tax297309258
Minority interest121121119
Other liabilities, total217256145
Total liabilities2,0462,1351,559
SHAREHOLDERS EQUITY
Common stock2,2042,1632,048
Additional paid-in capital------
Retained earnings (accumulated deficit)(1141)(860)(489)
Treasury stock - common(1.05)(5.21)(5.21)
Unrealized gain (loss)------
Other equity, total(12)(19)(6.74)
Total equity1,0511,2801,546
Total liabilities & shareholders' equity3,0973,4153,105
Total common shares outstanding734717708
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.